Singapore: Guidance on collaboration between competitors to supply essential goods and services during the COVID-19 pandemic

In brief

The COVID-19 pandemic has disrupted the supply of essential goods and services around the world, including Singapore, and such disruptions have required competitors to temporarily collaborate to sustain or improve the supply of essential goods and services. To provide clarity on whether such collaborations will fall afoul of the Singapore Competition Act (Cap. 50B) (the “Act”), the Competition and Consumer Commission of Singapore ("CCCS") has issued the "CCCS Guidance Note on Collaborations between Competitors in Response to the COVID-19 Pandemic" ("Guidance Note").


The Guidance Note sets out that CCCS will exceptionally assume that a collaboration is likely to generate net economic benefits and accordingly, is unlikely to infringe the prohibition against anti-competitive agreements under section 34 of the Act, provided that the collaboration:

  1. sustains or improves the supply of goods or services designated as "essential" by the Ministry of Trade and Industry, in Singapore ("Essentials");
  2. is limited in scope and time; and
  3. does not involve price-fixing, bid-rigging, market-sharing or output limitation.

The Guidance Note will only apply to collaborations put in place from 1 February 2020, and which will expire by 31 July 2021 ("Applicable Period"). That said, collaborations that involve price-fixing, bid-rigging, market-sharing or output limitation will continue to be prohibited unless they satisfy the net economic benefit criteria under the Third Schedule to the Act.

Businesses engaged in the supply of Essentials intending to temporarily collaborate with their competitors should ensure that their collaborations are in accordance with the Guidance Note.

Key takeaways

Under normal circumstances, collaborations between competitors will come under close scrutiny of the CCCS, as they infringe the prohibition against anti-competitive agreements under section 34 of the Act. However, recognising that businesses may be required to make prompt supply chain decisions, the CCCS has opted to assume that all collaborations between competitors relating to the supply chain for Essentials will generate NEB and accordingly, are unlikely to infringe prohibitions under the Act (instead of investigating such collaborations), as long as the above 3 requirements are satisfied. The CCCS will generally not investigate such collaborations.

The CCCS provided the following examples in its Guidance Note:

  1. joint production of Essentials where the collaboration allows businesses to produce the Essentials that they otherwise would not have been able to produce effectively alone;
  2. joint distribution and marketing of Essentials where the collaboration allows businesses to distribute and market the Essentials that they otherwise would not be able to distribute to/reach effectively alone;
  3. joint purchasing where the collaboration allows businesses to collectively bargain for lower prices for Essentials; and
  4. sharing of aggregate non-individualised information (or individualized information in certain cases) to facilitate the meeting of demand for Essentials, with adequate competition compliance safeguards in place.

However, the Guidance Note will not apply to:

  1. collaborations that fall outside of the Applicable Period i.e. 1 February 2020 to 31 July 2021; and
  2. agreements entered into with the Singapore Government or any statutory body, or conduct carried out on their behalf.

Importantly, the Guidance Note does not provide an absolute safe harbour for businesses to engage in anti-competitive behaviour with competitors. The CCCS remains empowered to commence investigations against businesses using the COVID-19 pandemic and the Guidance Notice as a guise for their anti-competitive activities.

The CCCS encourages businesses to:

  1. self-assess to determine if their collaboration falls within the framework of the Guidance Note;
  2. contact the CCCS for clarification at; or
  3. notify the CCCS for guidance or a decision on the application of the Act to a collaboration.

The list of Essentials include products and services from the following categories: Health and Social Services; Food; Energy, Water, Waste and Environment; Information and Communications; Defence and Security, Construction, Facilities Management and Critical Public Infrastructure; Manufacturing and Distribution; Legal Services; and Others. A detailed list of products and services listed as Essentials can be found in the Annex to the Guidance Note.

While the Guidance Note provides businesses with clarity on collaboration with competitors in relation to the supply of essential goods and services in Singapore, it also sends a clear message that the CCCS expects all businesses to continue complying with existing competition laws in spite of the ongoing COVID-19 pandemic. This is in line with the joint statement made by the ASEAN Experts Group on Competition (of which Singapore is a member of) in response to the COVID-19 pandemic (see here), which calls on all businesses in the ASEAN region to continue to comply with competition law despite the economic downturn.

Please do not hesitate to get in touch with us if you wish to discuss how this development may impact your business operations in Singapore.

For more information, please refer to the Guidance Note (see here) and the corresponding media release (see here).

* * * * *

Baker McKenzie Wong & Leow is a member firm of Baker & McKenzie International, a global law firm with member law firms around the world. In accordance with the common terminology used in professional service organizations, reference to a "partner" means a person who is a partner or equivalent in such a law firm. Similarly, reference to an “office” means an office of any such law firm. This may qualify as "Attorney Advertising" requiring notice in some jurisdictions. Prior results do not guarantee a similar outcome.

Contact Information

© 2021 Baker & McKenzie. Ownership: This site (Site) is a proprietary resource owned exclusively by Baker McKenzie (meaning Baker & McKenzie International and its member firms, including Baker & McKenzie LLP). Use of this site does not of itself create a contractual relationship, nor any attorney/client relationship, between Baker McKenzie and any person. Non-reliance and exclusion: All information on this Site is of general comment and for informational purposes only and may not reflect the most current legal and regulatory developments. All summaries of the laws, regulation and practice are subject to change. The information on this Site is not offered as legal or any other advice on any particular matter, whether it be legal, procedural or otherwise. It is not intended to be a substitute for reference to (and compliance with) the detailed provisions of applicable laws, rules, regulations or forms. Legal advice should always be sought before taking any action or refraining from taking any action based on any information provided in this Site. Baker McKenzie, the editors and the contributing authors do not guarantee the accuracy of the contents and expressly disclaim any and all liability to any person in respect of the consequences of anything done or permitted to be done or omitted to be done wholly or partly in reliance upon the whole or any part of the contents of this Site. Attorney Advertising: This Site may qualify as “Attorney Advertising” requiring notice in some jurisdictions. To the extent that this Site may qualify as Attorney Advertising, PRIOR RESULTS DO NOT GUARANTEE A SIMILAR OUTCOME. All rights reserved. The content of the this Site is protected under international copyright conventions. Reproduction of the content of this Site without express written authorization is strictly prohibited.